Part of our AI Trading ecosystem
AI Trading Tool
The main AI trading tool page
AI Stock Analysis
4,600+ stocks analyzed
AI Stock Picks
Daily AI-generated picks
AI Stock Picker
Scan the universe for ideas
Stock Recommendations
Ranked AI research ideas
AI Trading Signals
Real-time momentum alerts
AI Stock Screener
Scan 4,600+ stocks live
Best AI Trading Tools
#1 pick: Stockinhood
How AI Trading Works
The technology explained
AI Stock Predictions
Multi-timeframe targets
$88.70
Current Price
505.94M
Market Cap
11.3
P/E Ratio
$89.1
52W High
$50.8
52W Low
CEO
Richard L. Sowers
Employees
N/A
Year Founded
2007
Headquarters
La Jolla, California
Sector / Industry
Financial Services · Regional Banks
Market Cap
505.94M
Today's High
$88.97
Today's Low
$88.50
Open
$88.74
Previous Close
$88.30
52-Week High
$89.10
52-Week Low
$50.80
Today's Volume
9,943
Avg. Volume
7,904
Overnight Volume
N/A
Shares Outstanding
5.73M
P/E Ratio
11.30
EPS
$7.76
Beta
0.07
Dividend Yield
N/A
Live market stats are a premium feature
These stats are from a cached snapshot. Unlock real-time data with lifetime access — $19.99.
Quarterly expected vs. actual performance
| Quarter | Date | EPS Est. | EPS Actual | Surprise | Rev. Est. | Rev. Actual |
|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-20 | 2.00 | 2.27 | +14% | $31.5M | $32.8M |
| Q1 2026 | 2026-04-15 | 1.85 | 1.92 | +4% | $30.2M | $31.1M |
| Q4 2025 | 2026-01-20 | 1.77 | 1.71 | -3% | $32.47M | $31.9M |
| Q3 2025 | 2025-10-20 | 1.65 | 1.75 | +6% | $29.5M | $30.2M |
Earnings data is AI-compiled from public sources and may be delayed or approximate. Not financial advice.
Price History
Private Bancorp of America (PBAM) maintains a strong bullish outlook supported by unanimous analyst buy ratings. The company has demonstrated robust financial performance with consistent EPS growth and a strong net interest margin of 5.2%. Trading at a P/E ratio of approximately 11.3x-15.4x, the stock is considered undervalued relative to its future cash flow potential. Recent earnings reports show consistent beats, and the company's transition to the Nasdaq exchange in July 2026 has increased visibility and liquidity.
7-Day Target
$94.00
30-Day Target
$105.00
6-Month Target
$105.00
AI Confidence
Risk Level
Medium
Analyst Target
$3.5
The successful advancement of their lead asset, ivospemin, into late-stage trials for pancreatic cancer could offer a breakthrough in a high-mortality space, creating significant valuation upside through potential partnerships or acquisition.
As a clinical-stage company with limited cash flow, Panbela faces extreme dilution risk and high probability of failure given the technical challenges of late-stage oncology clinical trials.
Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for patients with urgent unmet medical needs, particularly in oncology and rare diseases. Their primary pipeline centers on polyamine metabolism inhibitors designed to disrupt the growth cycles of cancer cells.
Open PBAM in the full AI tools and run your own analysis: live charts, 7-day to 6-month targets, and risk checks. 15 minutes free, no card required.
Rather have it all, permanently?
30-day money-back guarantee • Secure payment by Square
Stockinhood's AI generates multi-timeframe price targets for PBAM (Private Bancorp of America, Inc.), including 7-day, 30-day, and 6-month outlooks based on market data, technical indicators, and news sentiment. These estimates are for informational purposes only and do not constitute financial advice.
Our AI assigns a sentiment signal (Bullish, Bearish, or Neutral) to PBAM based on multiple factors including price trends, momentum, and market conditions. The current AI signal is Bullish. This is AI-generated research, not financial advice — always consult a licensed advisor before investing.
The AI-generated price target for PBAM is based on multi-timeframe analysis and represents a hypothetical scenario, not a guarantee. The current price is $88.70. Price targets are educational estimates and should not be relied upon for investment decisions.
Significant ongoing cash burn and need for future capital raises High failure rate of clinical trials in pancreatic ductal adenocarcinoma Regulatory hurdles with the FDA regarding trial design and endpoints Limited commercial experience and dependence on a narrow pipeline All risk analysis is informational only and not financial advice.
Private Bancorp of America, Inc. (PBAM) operates in the Financial Services sector, specifically the Regional Banks industry. This classification helps investors understand the company's business focus and compare it with peers in the same sector.
AI Stock Analysis
AI research on 4,600+ stocks
Best AI Trading Tools
15 AI trading tools tested & compared
Stock Analysis
Browse 7,700+ AI stock predictions
Financial Blog
AI-generated market insights daily
Financial Glossary
40+ stock market terms defined
Free Calculators
Position size, dividend yield & risk-reward tools
Original Research
Citable AI stock-market data studies
Social Buzz
Real-time social sentiment tracking